Company Filing History:
1 out of 31 
1 out of 1 Years Active: 2001-2002
Title: Hubert E. Blum: Innovator in Hepatitis B Treatment
Introduction
Hubert E. Blum is a renowned inventor based in Freiburg, Germany, known for his groundbreaking contributions to pharmaceutical composition aimed at treating hepatitis B virus (HBV) infections. With a total of two patents to his name, Blum's work has made significant strides in the pharmaceutical industry, particularly in developing innovative treatment methodologies for viral infections.
Latest Patents
One of Hubert E. Blum's notable patents focuses on a pharmaceutical composition designed to treat hepatitis B virus (HBV) infection. The invention describes a pharmaceutical formulation that includes a soluble active agent, which interacts with critical binding sites between human interleukin 6 (hIL6) and pS1, as well as hIL6 and hepatocytes. This active agent is present in sufficient amounts to competitively bind to these sites, effectively preventing hIL6-mediated HBV infection of hepatocytes and other HBV-permissive cells. This innovative approach holds promise in effectively combating HBV infections.
Career Highlights
Throughout his career, Hubert E. Blum has collaborated with noteworthy organizations such as Hadasit Medical Research Services and Development Company and Hadasit & Medical Research Services & Development Company, Ltd. His work within these organizations has been pivotal in advancing research and developments in the medical field, demonstrating his commitment to improving health outcomes.
Collaborations
In addition to his work at Hadasit, Hubert E. Blum has collaborated with esteemed colleagues, including Eithan Galun and Orit Nahor. These partnerships have further enhanced his research endeavors, promoting a multidisciplinary approach to tackling complex medical challenges, particularly in the realm of viral infections.
Conclusion
Hubert E. Blum stands out as an innovative inventor whose contributions to the field of medicine have made a significant impact on the treatment of hepatitis B virus infections. With his patents offering promising avenues for therapeutic interventions, Blum's work continues to inspire future innovations within the pharmaceutical industry.